Renovaro BioSciences
Pre-clinicalHarnessing phenomics and AI to turn disease signals into new therapies. We uncover treatments by reading disease in motion, decoded by AI, confirmed in living systems, built for patients.
Founded
2013
Focus
BiologicsCell & Gene TherapyVaccines
About
Harnessing phenomics and AI to turn disease signals into new therapies. We uncover treatments by reading disease in motion, decoded by AI, confirmed in living systems, built for patients.
Funding History
2Total raised: $40M
PIPE$25MUndisclosedFeb 15, 2023
IPO$15MUndisclosedAug 15, 2021
Company Info
TypePrivate
Founded2013
LocationLos Angeles, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile